Burden of gastrointestinal disease in U.S. substantial

October 29, 2012
Burden of gastrointestinal disease in U.S. substantial
Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

(HealthDay)—Gastrointestinal diseases account for substantial morbidity, mortality, and cost in the United States, according to research published in the November issue of Gastroenterology.

Anne F. Peery, M.D., from the University of North Carolina in Chapel Hill, and colleagues reviewed data on the epidemiology of collected from the National Ambulatory Medical Care Survey; National Health and Wellness Survey; Nationwide Inpatient Sample; Surveillance, Epidemiology, and End Results Program; National Vital Statistics System; Thompson Reuters MarketScan; Medicare; Medicaid; and the Clinical Outcomes Research Initiative's National Endoscopic Database. Endoscopic use, costs, and trends were examined.

The researchers found that the most common gastrointestinal symptom prompting a clinic visit was abdominal pain (15.9 million visits) and the most common gastrointestinal diagnosis was gastroesophageal reflux (8.9 million visits). In the last 10 years, hospitalizations and mortality from Clostridium difficile infection doubled. The most common reason for hospitalization (274,119 discharges) was acute pancreatitis. Colorectal cancer was the leading cause of gastrointestinal-related mortality (52,394 deaths) and accounted for more than half of all . In 2009 there were 6.9 million upper, 11.5 million lower, and 228,000 biliary endoscopies performed, with total costs of $32.4 billion for outpatient gastrointestinal endoscopy examinations.

"In summary, we present a comprehensive and current estimate of the toll of gastrointestinal and in the United States," the authors write. "Payers, policy makers, clinicians, and others interested in resource utilization may use these statistics to better understand evolving disease trends and the best way to meet the challenge of these diseases."

Explore further: Death from GI bleeding decreased in United States in past two decades

More information: Abstract
Full Text

Related Stories

Death from GI bleeding decreased in United States in past two decades

October 22, 2012
The number of patients dying from upper gastrointestinal bleeding has decreased over the past two decades, a result researchers attribute to the advances in medical and endoscopic therapies introduced over the past 20 years, ...

Recommended for you

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

Testing the accuracy of FDA-approved and lab-developed cancer genetics tests

December 14, 2017
Cancer molecular testing can drive clinical decision making and help a clinician determine if a patient is a good candidate for a targeted therapeutic drug. Clinical tests for common cancer causing-mutations in the genes ...

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

Newest data links inflammation to chemo-brain

December 14, 2017
Inflammation in the blood plays a key role in "chemo-brain," according to a published pilot study that provides evidence for what scientists have long believed.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.